Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
6(43%)
Results Posted
0%(0 trials)
Terminated
1(7%)

Phase Distribution

Ph not_applicable
7
50%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution7 total trials
N/ANon-phased studies
7(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

6

trials recruiting

Total Trials

14

all time

Status Distribution
Active(6)
Completed(4)
Terminated(1)
Other(3)

Detailed Status

Recruiting6
Completed4
unknown3
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
6
Success Rate
80.0%
Most Advanced
N/A

Trials by Phase

N/A7 (100.0%)

Trials by Status

completed429%
terminated17%
unknown321%
recruiting643%

Recent Activity

Clinical Trials (14)

Showing 14 of 14 trials
NCT05994976

Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers

Recruiting
NCT04133077Not Applicable

Xenografts Development From Surgical Tumor Samples of Patients With Triple Negative or Luminal B Breast Cancer

Recruiting
NCT07097480Not Applicable

Virus Transmission to People Recently Bitten or With a History of Monkey Bites "SIMVIR

Recruiting
NCT06451744Not Applicable

Cellular and Molecular Biomarkers in Patients With Lichen Planus

Recruiting
NCT06718127Not Applicable

Description of the Immune Response to Yellow Fever Vaccination

Recruiting
NCT05784584

Early Anti-Retroviral Treatment in HIV- Infected Children

Completed
NCT05384522

Analysis of the Prognostic Role of Epigenetic Biomarkers in Relation to the Motor Decline in Parkinson's Disease

Unknown
NCT05793008Not Applicable

Characterization of priMary And sEcondary STress Related takOtsubo

Recruiting
NCT06046508

Migraine With Aura and Patent Foramen Ovale: Identification of Biomarkers to Select Patients In Whom Intervention Would Be Beneficial (MANET)

Unknown
NCT04373200Not Applicable

Human Ab Response & immunoMONItoring of COVID-19 Patients

Completed
NCT04387994

Determination of Circulating Placental Biomarkers Levels to Predict the Pregnancy Outcome of First Trimester After IVF.

Completed
NCT03903601

Concentration of Trimethylamine Oxide (TMAO) in Blood Plasma as a Risk Factor for Vascular Cerebral Damage

Unknown
NCT02393833Not Applicable

IBCSG Trial 22-00 Serum Substudy

Terminated
NCT04002570

Adjuvant Radiotherapy on Circulating Cells in Breast Cancer Patients

Completed

All 14 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
14